Advertisement

Topics

AstraZeneca GmbH Company Profile

12:18 EDT 20th September 2018 | BioPortfolio

Forschungsförderpreis – Imaging in Psychiatrie und Psychotherapie Der Preis wird während der DGPPN-Mitgliederversammlung, die im R ahmen des diesjährigen DGPPN-Kongresses in Berlin stattfindet, verliehen und soll für einen Forschungsaufenthalt im Ausland genutzt werden.
Ziel ist es, junge Wissenschaftler aus allen Fachbereichen, die bereits erste Erfahrungen mit Bildgebungsmethoden im Bereich der Psychiatrie und Psychotherapie gesammelt haben, durch einen mehr monatigen Auslandsaufenthalt in einem Labor höchster Exzellenz zu fördern. Dieser Aufenthalt ist innerhalb von zwölf Monaten nach der Preisverleihung durchzuführen. Antragsberechtigt sind alle Jungwissenschaftler (z.B. Mediziner, Psychologen, Physiker), die nicht älter als 35 Jahre sind.

Location

Johannisberger Straße 74 14197
Postfach
140201
Germany

Contact

Phone: (030) 884293 - 0
Fax: (030) 884293 - 41
Email: info@bsmo.de


News Articles [851 Associated News Articles listed on BioPortfolio]

AstraZeneca BioVenture Hub: A new way of building companies fast

Magus Bjorsne, CEO of AstraZeneca's BioVenture Hub, discusses how the capability, experience and expertise of AstraZeneca in helping mature Biotechs transition into product development.

M&As this week: AstraZeneca, Mega Labs, Toho Holdings

AstraZeneca has agreed to purchase an additional 5.7% stake in Circassia Pharmaceuticals in a cash transaction. AstraZeneca’s total share in the...Read More... The post M&As this week: AstraZe...

AstraZeneca changes contractors as HQ delayed again

AstraZeneca has switched building contractors in a bid to hasten progress on its delayed and over-budget new headquarters, which is under construction in Cambridge. An AstraZeneca spokesperson told p...

AstraZeneca improves diabetes pen to maintain its market share

The European Commission (EC) has approved AstraZeneca’s Bydureon BCise, a new weekly formulation of established GLP-1 diabetes drug with added benefit of glucose reduction, better weight loss result...

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

Tim Herpin, AstraZeneca: Achieving scientific leadership and restoring growth

In this interview filmed at BIO Europe in Vienna, Paul Larsmon talks to Tim Herpin, Vice President, Head of transactions, Business development, GPPS, AstraZeneca. They discuss the change in strategy a...

Astrazeneca top, GlaxoSmithKline flop - das steckt dahinter

Die beiden beiden Pharma-Konzerne GlaxoSmithKline und Astrazeneca sorgen heute für ein Wechselbad der Gefühle. Während Astrazeneca nach einem starken zweiten Quartal neue Rekordkurse markiert, muss...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Medical Science Liaisons in Real-World Evidence Studies: Experience of AstraZeneca Russia.

There is no doubt that real-world evidence studies have the potential to improve and accelerate the development and delivery of safe and cost-effective innovative medicines to patients as well as infl...

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

A purpose-designed monofilament-fibre pad for debridement of hard-to-reach wounds: experience in clinical practice.

Effective and comfortable debridement is an important part of managing complex wounds. This user test evaluated a monofilament-fibre pad (with handle) (Debrisoft Lolly, Lohmann & Rauscher GmbH & Co. K...

Clinical Trials [84 Associated Clinical Trials listed on BioPortfolio]

Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis

This study is to evaluate non inferiority of Eurofarma budesonide nasal spary x referral Astrazeneca budesonide. Half patients will receive Eurofarma medication and half patients will rece...

Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions

Subjects to compare the single dose bioavailability of Torrent's Esomeprazole Magnesium DR Capsules 40 mg and Nexium® 40 mg DR Capsules of AstraZeneca LP, USA. Dosing periods of studies w...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [601 Associated Companies listed on BioPortfolio]

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a leader in gastrointestin...

AstraZeneca Pharmaceuticals LP

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a lead...

AstraZeneca and The Medicines Company

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastro...

AstraZeneca HealthCare Foundation

Established in 1993, the AstraZeneca HealthCare Foundation is a Delaware not-for-profit corporation and a 501(c)(3) entity organized for charitable purposes including to promote p...

AstraZeneca AS

AstraZeneca er et av verdens ledende farmasøytiske selskaper. Vi bruker hvert år ca. 25 milliarder norske kroner på forskning verden over for å utvikle nye medisiner. Dette har resultert i en rekk...

More Information about "AstraZeneca GmbH" on BioPortfolio

We have published hundreds of AstraZeneca GmbH news stories on BioPortfolio along with dozens of AstraZeneca GmbH Clinical Trials and PubMed Articles about AstraZeneca GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AstraZeneca GmbH Companies in our database. You can also find out about relevant AstraZeneca GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record